EAM
BLACR

Exos Asset Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-178,900
Closed -$18.1K 109
2024
Q2
$18.1K Sell
178,900
-21,100
-11% -$2.13K 0.02% 83
2024
Q1
$27.2K Buy
+200,000
New +$27.2K 0.02% 103